130.60
전일 마감가:
$130.69
열려 있는:
$130.01
하루 거래량:
2.00M
Relative Volume:
0.91
시가총액:
$36.89B
수익:
$7.23B
순이익/손실:
$1.41B
주가수익비율:
26.23
EPS:
4.979
순현금흐름:
$1.09B
1주 성능:
-1.68%
1개월 성능:
-3.57%
6개월 성능:
-11.52%
1년 성능:
+7.60%
애질런트 테크놀로지스 Stock (A) Company Profile
명칭
Agilent Technologies Inc
전화
(408) 345-8886
주소
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, NTRA, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
A
Agilent Technologies Inc
|
130.60 | 37.52B | 7.23B | 1.41B | 1.09B | 4.979 |
|
TMO
Thermo Fisher Scientific Inc
|
517.60 | 186.32B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
193.62 | 134.82B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
564.98 | 41.53B | 4.45B | 1.10B | 1.06B | 13.59 |
|
NTRA
Natera Inc
|
283.80 | 38.88B | 2.50B | -226.32M | 71.51M | -1.6412 |
|
WAT
Waters Corp
|
378.89 | 36.82B | 3.77B | 449.25M | 240.68M | 7.8556 |
애질런트 테크놀로지스 Stock (A) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-20 | 개시 | HSBC Securities | Buy |
| 2026-01-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-12-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-12-09 | 개시 | Goldman | Buy |
| 2025-12-02 | 개시 | Morgan Stanley | Overweight |
| 2025-10-08 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-10-08 | 업그레이드 | UBS | Neutral → Buy |
| 2025-02-10 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-06-27 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-04-05 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-11-17 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-09-28 | 개시 | Bernstein | Mkt Perform |
| 2023-07-31 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-05-24 | 재확인 | Barclays | Equal Weight |
| 2023-05-24 | 재확인 | BofA Securities | Buy |
| 2023-05-24 | 재확인 | Citigroup | Neutral |
| 2023-05-24 | 재확인 | Credit Suisse | Outperform |
| 2023-05-24 | 재확인 | Evercore ISI | Outperform |
| 2023-05-24 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | 재확인 | Robert W. Baird | Outperform |
| 2023-05-24 | 재확인 | SVB Securities | Outperform |
| 2023-05-24 | 재확인 | Stifel | Hold |
| 2023-05-24 | 재확인 | TD Cowen | Outperform |
| 2023-05-24 | 재확인 | Wells Fargo | Overweight |
| 2023-05-11 | 개시 | Barclays | Equal Weight |
| 2023-01-10 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-07-20 | 개시 | UBS | Buy |
| 2022-07-08 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | 재확인 | BofA Securities | Buy |
| 2022-02-23 | 재확인 | Citigroup | Buy |
| 2022-02-23 | 재확인 | Cowen | Outperform |
| 2022-02-23 | 재확인 | Evercore ISI | Outperform |
| 2022-02-23 | 재확인 | Stifel | Hold |
| 2022-02-23 | 재확인 | Wells Fargo | Overweight |
| 2021-11-23 | 재확인 | BofA Securities | Buy |
| 2021-11-23 | 재확인 | Cowen | Outperform |
| 2021-11-23 | 재확인 | Stifel | Hold |
| 2021-03-18 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-02-17 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-12-02 | 개시 | Goldman | Buy |
| 2020-11-25 | 업그레이드 | UBS | Neutral → Buy |
| 2020-11-17 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | 개시 | Atlantic Equities | Neutral |
| 2020-08-19 | 재확인 | BofA Securities | Neutral |
| 2020-08-19 | 재확인 | Citigroup | Neutral |
| 2020-08-19 | 재확인 | Jefferies | Buy |
| 2020-08-19 | 재확인 | Robert W. Baird | Outperform |
| 2020-08-19 | 재확인 | SVB Leerink | Outperform |
| 2020-08-19 | 재확인 | Stifel | Hold |
| 2020-08-19 | 재확인 | Wells Fargo | Overweight |
| 2020-02-24 | 다운그레이드 | Needham | Buy → Hold |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-11-26 | 재확인 | Needham | Buy |
| 2019-11-15 | 개시 | Stifel | Hold |
| 2019-10-18 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-07-16 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | 다운그레이드 | Barclays | Overweight → Equal Weight |
모두보기
애질런트 테크놀로지스 주식(A)의 최신 뉴스
Agilent (A) Unveils AI-Enhanced Software for Improved Cell Imagi - GuruFocus
Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight - 巴士的報
Agilent 1260 Infinity II LC System from Agilent Technologies Inc.midrange workhorse for US analyt - AD HOC NEWS
Agilent TechnologiesIgnite raises the full-year outlook - AD HOC NEWS
Agilent Bravo NGS Auto Prep System from Agilent Technologies Inc.Automating genomic workflows for - AD HOC NEWS
Jefferies Initiates Agilent Technologies(A.US) With Buy Rating, Announces Target Price $550 - Moomoo
Agilent Technologies consensus picture, shares trade steadily on the NYSE - AD HOC NEWS
Form 4 Agilent Technologies For: 29 June By Investing.com - Investing.com South Africa
Agilent Technologies Inc. stock underperforms Monday when compared to competitors - MarketWatch
Agilent (NYSE: A) SVP surrenders 30 shares to cover RSU tax liability - Stock Titan
InfinityLab LC Series 1260 Infinity II from Agilent Technologies Inc.flexible mid-range workhorse - AD HOC NEWS
Accurate mAb Sizing Using The NIST mAb As A Ladder For The Agilent ProteoAnalyzer System - Bioprocess Online
Agilent Technologies sets $600 million note deal, shares supported by debt market access - AD HOC NEWS
Agilent Technologies, Inc. (A) Stock Analysis: Unpacking a 17.88% Potential Upside for Investors - DirectorsTalk Interviews
Agilent Inlet Liners from Agilent Technologies Inc.small glass parts, big impact on GC precision - AD HOC NEWS
Oxidative Stress Assay Market Size to Reach USD 3.25 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
The 8890 GC System from Agilent Technologies Inc.a classic gas chromatograph for modern labs - AD HOC NEWS
Why Agilent Stock Is Slipping Premarket Today - Stocktwits
InfinityLab LC Series from Agilent Technologies Inc.modular HPLC workhorse for busy labs - Ad-hoc-news.de
Agilent Completes Acquisition Of Biocare Medical - Pulse 2.0
Agilent lifts outlook after Q2, shares hold above consensus - Ad-hoc-news.de
Enterprise value to EBIT forward of Agilent Technologies, Inc. – BOATS:A - TradingView
A6433334 Latest News and Headlines - TradingView
Price to earnings forward of Agilent Technologies, Inc. – NYSE:A - TradingView
Agilent (A) Receives Outperform Rating with $155 Price Target - GuruFocus
Agilent Completes $600 Million Senior Notes Offering - The Globe and Mail
There's A Lot To Like About Agilent Technologies' (NYSE:A) Upcoming US$0.255 Dividend - 富途牛牛
Bernstein SocGen resumes Agilent stock coverage with outperform rating - Investing.com UK
Agilent Technologies, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh - TradingView
Bernstein SocGen resumes Agilent stock coverage with outperform rating By Investing.com - Investing.com South Africa
Why Is Agilent (A) Up 0.1% Since Last Earnings Report? - Yahoo Finance
Is Agilent Technologies (NYSE:A) Still A Reliable Dividend Story? - Kalkine Media
Agilent finalizes Biocare Medical takeover - MedTech Dive
Agilent 8890 GC System from Agilent Technologies Inc.flexible chromatograph for demanding labs - Ad-hoc-news.de
Agilent Technologies, Inc. (NYSE:A) Passed Our Checks, And It's About To Pay A US$0.255 Dividend - simplywall.st
Agilent Technologies completes Biocare deal, shares react to healthcare expansion - Ad-hoc-news.de
Agilent Technologies, Inc. Actuals & Estimates (NYSE:A) - TradingView
Agilent Technologies Closes $600 Million 4.900% Senior Notes Due 2032 Offering and Registration Rights Agreement - Minichart
The 6495D Triple Quadrupole LC/MS from Agilent Technologies Inc.ultra-low detection limits for de - Ad-hoc-news.de
A6433334 Bond Coupon Analysis — Rate & Payments - TradingView
Agilent Technologies, Inc. Actuals & Estimates (BIVA:A) - TradingView
Agilent Technologies (A) Announces $600 Million Senior Notes Off - GuruFocus
Agilent (A) Stock Trades Up, Here Is Why - Yahoo Finance
Agilent Technologies, Inc. Actuals & Estimates (EUROTLX:4A) - TradingView
Agilent Technologies Inc. stock outperforms competitors on strong trading day - MarketWatch
Agilent Sells $600 Million of 4.900% Senior Notes Due 2032 in Private Offering - TradingView
Agilent (NYSE: A) issues $600M 4.900% senior notes maturing in 2032 - Stock Titan
Agilent Technologies, Inc. Closes $600 Million Private Placement Of 4.900% Senior Notes Due 2032 - marketscreener.com
Agilent Technologies, Inc. (NYSE:A) completed the acquisition of Biocare Medical, LLC from an investor group led by Excellere Capital Fund III LP, a fund managed by Excellere Capital Management LLC and GHO Capital Partners LLP. - marketscreener.com
Agilent Technologies earnings outlook steady, shares tracked on NYSE - Ad-hoc-news.de
Agilent completes acquisition of Biocare Medical - Investing.com UK
애질런트 테크놀로지스 (A) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):